These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8897852)

  • 1. Effects of chronic renal failure on plasma clearance of insulin-like growth factor I, des-(1-3)IGF-I, and LR3IGF-I.
    Gillespie CM; Hazel SJ; Walton PE; Martin AA
    Am J Physiol; 1996 Oct; 271(4 Pt 1):E649-57. PubMed ID: 8897852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats.
    Bastian SE; Walton PE; Wallace JC; Ballard FJ
    J Endocrinol; 1993 Aug; 138(2):327-36. PubMed ID: 7693845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys.
    Tomas FM; Walton PE; Dunshea FR; Ballard FJ
    J Endocrinol; 1997 Nov; 155(2):377-86. PubMed ID: 9415072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of insulin-like growth factor I (IGF-I) bioactivity in vivo: further characterization of an IGF-I-enhancing antibody.
    Hill RA; Pell JM
    Endocrinology; 1998 Mar; 139(3):1278-87. PubMed ID: 9492063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum.
    Durham SK; Mohan S; Liu F; Baker BK; Lee PD; Hintz RL; Conover CA; Powell DR
    Pediatr Res; 1997 Sep; 42(3):335-41. PubMed ID: 9284274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure.
    Rabkin R; Fervenza FC; Maidment H; Ike J; Hintz R; Liu F; Bloedow DC; Hoffman AR; Gesundheit N
    Kidney Int; 1996 Apr; 49(4):1134-40. PubMed ID: 8691735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins.
    Lord AP; Martin AA; Ballard FJ; Read LC
    J Endocrinol; 1994 Jun; 141(3):505-15. PubMed ID: 7520931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs.
    Ballard FJ; Walton PE; Bastian S; Tomas FM; Wallace JC; Francis GL
    Growth Regul; 1993 Mar; 3(1):40-4. PubMed ID: 7683526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.
    Tönshoff B; Powell DR; Zhao D; Durham SK; Coleman ME; Domené HM; Blum WF; Baxter RC; Moore LC; Kaskel FJ
    Endocrinology; 1997 Mar; 138(3):938-46. PubMed ID: 9048593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of an analog of insulin-like growth factor-I in blood plasma using a novel enzyme-linked immunosorbent assay.
    Gajanandana O; Irvine K; Grant PA; Francis GL; Knowles SE; Wrin J; Wallace JC; Owens PC
    J Endocrinol; 1998 Mar; 156(3):407-14. PubMed ID: 9582496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of circulating IGF-I and LR3IGF-I from blood to extracellular wound fluid sites in rats.
    Bastian SE; Walton PE; Belford DA
    J Endocrinol; 2000 Jan; 164(1):77-86. PubMed ID: 10607940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of insulin-like growth factor-I peptides in rats with acute renal failure.
    Martin AA; Gillespie CM; Moore L; Ballard FJ; Read LC
    J Endocrinol; 1994 Jan; 140(1):23-32. PubMed ID: 8138750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of IGF system component levels and mitogenic activity of uremic serum on normal human osteoblasts.
    Wagner MS; Stracke S; Jehle PM; Keller F; Zellner D; Baylink DJ; Mohan S
    Nephron; 2000 Feb; 84(2):158-66. PubMed ID: 10657717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.
    Dubaquié Y; Mortensen DL; Intintoli A; Hogue DA; Nakamura G; Rancatore P; Lester P; Sadick MD; Filvaroff E; Fielder PJ; Lowman HB
    Endocrinology; 2001 Jan; 142(1):165-73. PubMed ID: 11145579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential intestinal delivery of long[Arg3] insulin-like growth factor (LR3IGF-I) over IGF-I in preweaning and adult rats.
    Shoubridge CA; Read LC
    Endocrinology; 2003 May; 144(5):1887-93. PubMed ID: 12697696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
    Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
    Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.